Calcitriol stimulates prolactin expression in non-activated human peripheral blood mononuclear cells: Breaking paradigms

Cytokine

Volumn 55, Issue 2, 2011, Pages 188-194

  Díaz, Lorenza ^a   Martínez Reza, Isela ^a   García Becerra, Rocío ^a   González, Leticia ^a   Larrea, Fernando ^a   Méndez, Isabel ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

CYP24A1; Mononuclear cells; PXR; VDR; Vitamin D

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; COLECALCIFEROL RECEPTOR; CYTOCHROME P450; PHYTOHEMAGGLUTININ; PREGNANE X RECEPTOR; PROLACTIN; PROTEIN CYP24A1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYP24A1 GENE; DRUG MECHANISM; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LEUKEMIA CELL LINE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; UPREGULATION;

ADULT; ANIMALS; CALCITRIOL; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PROLACTIN; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID; STEROID HYDROXYLASES; VITAMINS;

EID: 79959557190     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.04.013     Document Type: Article

References (42)

1. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 2010, 321:103-111.
2. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
3. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010, 10:482-496.
4. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008, 4:404-412.
5. Adorini L., Amuchastegui S., Daniel K.C. Prevention of chronic allograft rejection by vitamin D receptor agonists. Immunol Lett 2005, 100:34-41.
6. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000, 374:334-338.
7. Manolagas S.C., Provvedini D.M., Tsoukas C.D. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 1985, 43:113-122.
8. Manolagas S.C., Werntz D.A., Tsoukas C.D., Provvedini D.M., Vaughan J.H. 1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med 1986, 108:596-600.
9. Provvedini D.M., Rulot C.M., Sobol R.E., Tsoukas C.D., Manolagas S.C. 1-alpha, 25-Dihydroxyvitamin D3 receptors in human thymic and tonsillar lymphocytes. J Bone Miner Res 1987, 2:239-247.
10. Yu X.P., Hustmyer F.G., Garvey W.T., Manolagas S.C. Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: immunologic crossreactivity and inverse regulation with the vitamin D receptor. Proc Natl Acad Sci USA 1991, 88:8347-8351.
11. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010, 39:365-379. table of contents.
12. Ben-Jonathan N., Mershon J.L., Allen D.L., Steinmetz R.W. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996, 17:639-669.
13. Montgomery D.W. Prolactin production by immune cells. Lupus 2001, 10:665-675.
14. Kelley K.W., Weigent D.A., Kooijman R. Protein hormones and immunity. Brain Behav Immun 2007, 21:384-392.
15. Mendez I., Alcocer-Varela J., Parra A., Lava-Zavala A., de la Cruz D.A., Alarcon-Segovia D., et al. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin. Lupus 2004, 13:45-53.
16. Haug E., Bjoro T., Gautvik K.M. A permissive role for extracellular Ca2+ in regulation of prolactin production by 1,25-dihydroxyvitamin D3 in GH3 pituitary cells. J Steroid Biochem 1987, 28:385-391.
17. Castillo A.I., Jimenez-Lara A.M., Tolon R.M., Aranda A. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Mol Endocrinol 1999, 13:1141-1154.
18. Tornquist K. Effect of 1,25-dihydroxyvitamin D3 on rat pituitary prolactin release. Acta Endocrinol (Copenh) 1987, 116:459-464.
19. Berwaer M., Martial J.A., Davis J.R. Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 1994, 8:635-642.
20. Gellersen B., Kempf R., Telgmann R., DiMattia G.E. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 1994, 8:356-373.
21. Delvin E.E., Gagnon L., Arabian A., Gibb W. Influence of calcitriol on prolactin and prostaglandin production by human decidua. Mol Cell Endocrinol 1990, 71:177-183.
22. Towers T.L., Freedman L.P. Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. J Biol Chem 1998, 273:10338-10348.
23. Ross T.K., Darwish H.M., Moss V.E., DeLuca H.F. Vitamin D-influenced gene expression via a ligand-independent, receptor-DNA complex intermediate. Proc Natl Acad Sci USA 1993, 90:9257-9260.
24. Zarrabeitia M.T., Riancho J.A., Rodriguez-Valverde V., Farinas M.C., Gonzalez-Macias J. Role of monocytes in the inhibitory effect of calcitriol on PHA-stimulated lymphocytes. Blut 1987, 54:343-349.
25. Pellegrini I., Lebrun J.J., Ali S., Kelly P.A. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992, 6:1023-1031.
26. Gellersen B., DiMattia G.E., Friesen H.G., Bohnet H.G. Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Endocrinology 1989, 125:2853-2861.
27. Sharma O.P. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000, 6:442-447.
28. Barbour G.L., Coburn J.W., Slatopolsky E., Norman A.W., Horst R.L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 1981, 305:440-443.
29. Turkington R.W., MacIndoe J.H. Hyperprolactinemia in sarcoidosis. Ann Intern Med 1972, 76:545-549.
30. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004, 29:664-673.
31. Luo W., Karpf A.R., Deeb K.K., Muindi J.R., Morrison C.D., Johnson C.S., et al. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. Cancer Res 2010, 70:5953-5962.
32. Johnson C.S., Chung I., Trump D.L. Epigenetic silencing of CYP24 in the tumor microenvironment. J Steroid Biochem Mol Biol 2010, 121:338-342.
33. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 1993, 7:1244-1255.
34. Sunn K.L., Cock T.A., Crofts L.A., Eisman J.A., Gardiner E.M. Novel N-terminal variant of human VDR. Mol Endocrinol 2001, 15:1599-1609.
35. Ebihara K., Masuhiro Y., Kitamoto T., Suzawa M., Uematsu Y., Yoshizawa T., et al. Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway. Mol Cell Biol 1996, 16:3393-3400.
36. Dubrac S., Elentner A., Ebner S., Horejs-Hoeck J., Schmuth M. Modulation of T lymphocyte function by the pregnane X receptor. J Immunol 2010, 184:2949-2957.
37. Zhou C., Assem M., Tay J.C., Watkins P.B., Blumberg B., Schuetz E.G., et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006, 116:1703-1712.
38. Holick M.F. Stay tuned to PXR: an orphan actor that may not be D-structive only to bone. J Clin Invest 2005, 115:32-34.
39. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
40. Baeke F., Korf H., Overbergh L., van Etten E., Verstuyf A., Gysemans C., et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol 2010, 121:221-227.
41. Adams J.S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008, 4:80-90.
42. Adams J.S. Vitamin D as a defensin. J Musculoskelet Neuronal Interact 2006, 6:344-346.